(Q61975166)

English

A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZYD1, Following Subcutaneous Administration in Healthy Volunteers

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

short name

ZYD1 (English)

0 references

title

A Randomized, Double-blind, Placebo-controlled Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZYD1, a Selective Glucagon-like Peptide (GLP) 1 Agonist, Following Subcutaneous Administration in Healthy Volunteers. (English)

0 references

0 references

0 references

February 2011

0 references

end time

March 2012